Annals of Emergency Medicine
Volume 57, Issue 1 , Pages 1-12 , January 2011

A Clinical Prediction Model to Estimate Risk for 30-Day Adverse Events in Emergency Department Patients With Symptomatic Atrial Fibrillation

Presented at the 2009 American College of Emergency Physicians Scientific Assembly, October 2009, Boston, MA.

  • Tyler W. Barrett, MD, MSCI

      Affiliations

    • Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN
    • Corresponding Author InformationAddress for correspondence: Tyler W. Barrett, MD, MSCI, Department of Emergency Medicine, Vanderbilt University Medical Center, 703 Oxford House, Nashville, TN 37232-4700; 615-936-0253, fax 615-936-1316
    • ,
  • Amy R. Martin, MD

      Affiliations

    • Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN
    • ,
  • Alan B. Storrow, MD

      Affiliations

    • Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN
    • ,
  • Cathy A. Jenkins, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN
    • ,
  • Frank E. Harrell Jr, PhD

      Affiliations

    • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN
    • ,
  • Stephan Russ, MD, MPH

      Affiliations

    • Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN
    • ,
  • Dan M. Roden, MD

      Affiliations

    • Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN
    • ,
  • Dawood Darbar, MD

      Affiliations

    • Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN

Received 11 February 2010 ,Revised 13 May 2010 ,Accepted 25 May 2010.

References 

  1. Benjamin EJ, Chen PS, Bild DE, et al. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2009;119:606–618
  2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375
  3. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation (Analysis and implications). Arch Intern Med. 1995;155:469–473
  4. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952
  5. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476–484
  6. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley Study. Am J Med. 2002;113:359–364
  7. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–988
  8. Wolf PA, Dawber TR, Thomas HE, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 1978;28:973–977
  9. Koenig BO, Ross MA, Jackson RE. An emergency department observation unit protocol for acute-onset atrial fibrillation is feasible. Ann Emerg Med. 2002;39:374–381
  10. Lip GY, Watson T, Shantsila E. Anticoagulation for stroke prevention in atrial fibrillation: is gender important?. Eur Heart J. 2006;27:1893–1894
  11. McDonald AJ, Pelletier AJ, Ellinor PT, et al. Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med. 2008;51:58–65
  12. Scott PA, Pancioli AM, Davis LA, et al. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke. 2002;33:2664–2669
  13. Coyne KS, Paramore C, Grandy S, et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006;9:348–356
  14. Friberg J, Buch P, Scharling H, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology. 2003;14:666–672
  15. Estes NA, Halperin JL, Calkins H, et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation. 2008;117:1101–1120
  16. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:854–906
  17. Decker WW, Smars PA, Vaidyanathan L, et al. A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation. Ann Emerg Med. 2008;52:322–328
  18. Stiell IG, Clement CM, Symington C, et al. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. Acad Emerg Med. 2007;14:1158–1164
  19. Zimetbaum P, Reynolds MR, Ho KK, et al. Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs. Am J Cardiol. 2003;92:677–681
  20. Gilbert EH, Lowenstein SR, Koziol-McLain J, et al. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med. 1996;27:305–308
  21. Dankner R, Shahar A, Novikov I, et al. Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management. Cardiology. 2008;112:270–278
  22. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–2870
  23. Khumri TM, Idupulapati M, Rader VJ, et al. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation. Am J Cardiol. 2007;99:1733–1736
  24. Loricchio ML, Cianfrocca C, Pasceri V, et al. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol. 2007;99:1421–1424
  25. Mahe I, Drouet L, Simoneau G, et al. D-dimer can predict survival in patients with chronic atrial fibrillation. Blood Coagul Fibrinolysis. 2004;15:413–417
  26. Miyasaka Y, Barnes ME, Gersh BJ, et al. Changing trends of hospital utilization in patients after their first episode of atrial fibrillation. Am J Cardiol. 2008;102:568–572
  27. Perrea DN, Ekmektzoglou KA, Vlachos IS, et al. A formula for the stratified selection of patients with paroxysmal atrial fibrillation in the emergency setting: a retrospective pilot study. J Emerg Med. 2008 Sep 29;[Epub ahead of print]
  28. Vaglio JR, Kucera S, Stubblefield G, et al. Genetic and clinical predictors of response to rate control therapy in patients with atrial fibrillation. Circulation. 2008;118:S828
  29. Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003;290:1049–1056
  30. Zimetbaum PJ, Josephson ME, McDonald MJ, et al. Incidence and predictors of myocardial infarction among patients with atrial fibrillation. J Am Coll Cardiol. 2000;36:1223–1227
  31. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) Study. J Am Coll Cardiol. 2003;41:1690–1696
  32. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834–1840
  33. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833
  34. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer; 2009;
  35. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387
  36. Glantz SA, Slinker BK. Primer of Applied Regression and Analysis of Variance. New York, NY: McGraw-Hill; 1990;
  37. Moons KG, Donders AR, Steyerberg EW, et al. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. J Clin Epidemiol. 2004;57:1262–1270
  38. Donders AR, van der Heijden GJ, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087–1091
  39. van der Heijden GJ, Donders AR, Stijnen T, et al. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol. 2006;59:1102–1109
  40. Harrell FE. Hmisc: Harrell miscellaneous (R package version 3.6-0). http://CRAN.R- project.org/package=Hmisc2009;Accessed April 13, 2009.
  41. Harrell FE. (2009). Design: design package. R package version 2.2-0. http://CRAN.R-project.org/package=DesignAccessed April 13, 2009
  42. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009;http://www.R-project.org2009;ISBN 3-900051-07-0. Accessed April 13, 2009
  43. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. In: New York, NY: Springer; 2001;p. 1–568
  44. del Arco C, Martin A, Laguna P, et al. Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 Study. Ann Emerg Med. 2005;46:424–430
  45. Gibler WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 1995;25:1–8
  46. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia (CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin). JAMA. 2000;283:749–755
  47. Dogan A, Avsar A, Ozturk M. P-wave dispersion for predicting maintenance of sinus rhythm after cardioversion of atrial fibrillation. Am J Cardiol. 2004;93:368–371
  48. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N–9N
  49. Lip GY, Patel JV, Hughes E, et al. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke. 2007;38:1229–1237
  50. Liu T, Li G, Li L, et al. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol. 2007;49:1642–1648
  51. Novo G, Mansueto P, La Franca ML, et al. Risk factors, atrial fibrillation and thromboembolic events. Int Angiol. 2008;27:433–438
  52. Shimizu H, Murakami Y, Inoue S, et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke. 2002;33:1005–1010
  53. Vene N, Mavri A, Kosmelj K, et al. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost. 2003;90:1163–1172
  54. Watanabe D, Shizuka K, Koyama S, et al. Plasma brain natriuretic peptide levels indicating thromboembolism in very elderly patients with non-valvular atrial fibrillation. Circ J. 2007;71:1446–1451
  55. Watanabe E, Arakawa T, Uchiyama T, et al. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol. 2006;108:346–353
  56. Zohar P, Kovacic M, Brezocnik M, et al. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling. Europace. 2005;7:500–507
  57. Brown AM, Sease KL, Robey JL, et al. The risk for acute coronary syndrome associated with atrial fibrillation among ED patients with chest pain syndromes. Am J Emerg Med. 2007;25:523–528

 Provide feedback on this article at the journal's Web site, www.annemergmed.com.

 A podcast for this article is available at www.annemergmed.com.

 Supervising editor: Keith A. Marill, MD

 Author contributions: All authors contributed significantly to the study and the preparation of the article. TWB, ABS, DMD, and DD were responsible for the conception and design of the study. TWB, ARM, and SR were responsible for data acquisition, data entry, and preliminary data analysis. CAJ and FEH performed all statistical analyses. All authors participated in the drafting and multiple revisions of the article and gave final approval to the submitted work. TWB takes responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. The study was entirely funded by the Vanderbilt University Medical Center Physician Scientist Development Program (supported in part by Vanderbilt CTSA grant 1 UL1 RR024975 from NCRR/NIH) and the Department of Emergency Medicine Research Division. Dr. Darbar and Dr. Roden are supported in part by NIH grants U01 HL65962 and R01 HL092217.

 Publication date: Available online August 21, 2010.

 Earn CME Credit: Continuing Medical Education is available for this article at: www.ACEP-EMedHome.com.

 Reprints not available from the authors.

 Please see page 2 for the Editor's Capsule Summary of this article.

PII: S0196-0644(10)00556-1

doi: 10.1016/j.annemergmed.2010.05.031

Annals of Emergency Medicine
Volume 57, Issue 1 , Pages 1-12 , January 2011

Article Tools

* Image Usage & Resolution